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Abstract 
Ovarian tumors associated with hormonal
changes of the peripheral iso-sexual precocious
puberty are of common presentation. We
describe here a rare case of juvenile granulosa
cell tumor in a female with central precocious
puberty (CPP). An 8-year old girl with CPP pre-
sented with vaginal bleeding four months after
the diagnosis and before starting treatment
with gonadotropin-releasing hormone (GnRH)-
analogs. Suppression of basal follicle-stimula-
ting hormone (FSH) level, elevation of serum
estradiol, progesterone and Cancer Antigen-125
were documented. Abdominal ultrasound exam-
ination (US) and magnetic resonance imaging
showed a pelvic mass affecting the left ovary. A
left salpingo-oophorectomy was performed and
the mass was totally resected. Juvenile granu-
losa cell ovarian tumor was diagnosed. One
month post surgery, estradiol and progesterone
decreased to values of the first evaluation and
FSH increased; Cancer Antigen-125 resulted
normal while ultrasound pelvic examination
showed absence of pelvic masses. In our
patient, the tumor had grown very quickly since
hormonal data demonstrated a CPP without any
evidence of ovarian mass on US only four
months before diagnosis. The overstimulation
of the FSH or aberrant activation of FSH recep-
tors may have contributed to the development of
the mass.
Introduction
Ovarian tumors are rare in children and
adolescents. Malignant ovarian neoplasms
comprise approximately 1% of all childhood
cancers and represent the most common gyne-
cological tumors. Eighty percent are germ cell
tumors and only 5-8% of cases are of sex cord
stromal origin. Granulosa cell tumors (GCTs)
are a group of estrogen producing sex cord
stromal tumors that account for approximately
2% of all ovarian tumors.1-3 On the basis of his-
tological characteristics and age of onset,
these tumors are divided into adult type (95%
of cases) and juvenile type (5% of cases).
Precocious pseudo-puberty, vaginal bleeding
and irregular menstruation are a common
presentation of these tumors associated with
hormonal changes.1,2 We describe here a rare
case of juvenile granulosa cell tumor (JGCT)
in a girl with central precocious puberty.
Case Report
A Caucasian female with no significant past
medical history presented with breast enlarge-
ment (Tanner stage B2) and pubic hair (PH2)
at the age of 7 years and 9 months. At her first
examination (8 years and 5 months), anthro-
pometric evaluation revealed height 126.4 cm
(50th percentile), weight 32 kg (97th per-
centile), and body mass index 20.3 kg/m2 (75-
90th percentile). She had no headache or visu-
al complaints and did not demonstrate any
neurological signs; physical examination was
unremarkable. 
Endocrine evaluation revealed elevation of
GnRH-stimulated luteinizing hormone (LH)
and FSH peak (Table 1); other hormonal levels,
related to adrenal and thyroid function, were
normal. Bone age advancement (SDS-BA 2.1),
without growth spurt, was found. Tumor mark-
ers were negative.
An ultrasound examination (US) showed a
pubertal uterus; the left and right ovaries were
normal (Figure 1A). 
Based on history and pubertal hormonal pro-
file the diagnosis of central precocious puberty
was formulated. After four months, during com-
pletion of screening tests and magnetic reso-
nance imaging (MRI) of the hypothalamic-pitu-
itary region and before starting treatment with
GnRH analogs, the patient presented a vaginal
bleeding without other symptoms or progres-
sion of pubertal development. Physical exami-
nation evidenced a palpable fullness in the
pelvic region associated with increase in
abdominal girth. Suppression of basal FSH
level, elevation of serum estradiol, progesterone
and CA125 were observed (Table 1). Pelvic
ultrasound demonstrated the presence of a
huge lesion (13¥8 cm) affecting the left ovary
(Figure 1B). An MRI of the abdomen confirmed
the US findings of a pelvic capsulated mixed
mass (13¥13.7¥6 cm) arising from the left
ovary (Figure 1C). The girl underwent laparoto-
my and a left salpingo-oophorectomy, and a
complete mass resection was performed. On
gross examination, the tumor originated from
the left ovary that was substituted by a gray
mass with solid and cystic components and
hemorrhagic areas (Figure 1D). The microscop-
ic appearance was characterized by a prolifera-
tion of the sex-stromal cells with high mitotic
activity and low-grade cell atypia. Juvenile gran-
ulosa cell ovarian tumor was diagnosed. Her
postoperative course was unremarkable. No
chemotherapy or radiation was necessary. 
The girl did not start suppressive therapy
with GnRH analogs in order to permit a follow
up without interfering agents. At one month
post surgery, estradiol and progesterone
decreased to values of the first evaluation and
FSH increased; CA-125 resulted normal while
pelvic ultrasound showed an absence of pelvic
masses. Seven months after surgery there
were no signs of re-occurrence of tumor. MRI
of the hypothalamic pituitary region revealed
the presence of a pineal cyst. Discussion 
Precocious puberty (PP) in girls is defined
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as the development of secondary sexual char-
acteristics before the age of eight years. Two
types of PP are recognized: central precocious
puberty (CPP) and peripheral precocious
puberty (PPP). CPP is caused by early activa-
tion of the hypothalamus-pituitary-gonadal
axis. It is usually idiopathic but secondary
causes include tumors, infections, congenital
defects, and radiation or injury to the brain.
PPP does not involve the HPG axis. It is caused
by release of estrogen or testosterone from
abnormal organs and causes include gonadal
tumor.4
Ovarian tumors are uncommon lesions in
children. Their approximate incidence is esti-
mated at approximately 2.6 cases annually per
100,000 girls, and malignant ovarian tumors
represent approximately 1% of all childhood
cancers.2 The incidence of GCTs, which is a
subset of sex cord stromal tumors, varies from
0.4 to 1.7 cases per 100,000 women. Only
approximately 5% of all GCTs cases are of juve-
nile type and occur in pre-menarchal girls and
young women.1-3
The presenting complaints in patients with
ovarian masses are non-specific, making diag-
nosis difficult. Acute or chronic abdominal
pain and abdomino-pelvic mass are the most
common initial symptoms. Endocrine signs
(pseudo-precocious puberty, signs of viriliza-
tion, vaginal secretions, irregular uterine
bleeding) can reveal some secreting ovarian
tumors.5 We describe a rare case in which
ovarian JGCT occurred with vaginal bleeding
four months after diagnosis of central preco-
cious puberty. 
Central precocious puberty has been previ-
ously reported in some girls with ovarian GCTs
and in these patients the signs of puberty
developed concomitantly with the mass or
some years after its removal. Gonadotropin
stimulation might play a role in the develop-
ment of the ovarian tumors.6 In our patient,
both hormonal data and US images demon-
strated a CPP without ovarian masses only
four months before diagnosis. Given this, the
possibility that overstimulation of the FSH may
have contributed to the development of the
mass cannot be ruled out; stimulation of the
ovary by gonadotropin might have a direct car-
cinogenic effect.7 In addition, even if activat-
ing mutations of FSHR were not investigated,
the growth of ovarian tumor in our patient
might have been caused by aberrant activation
of FSHR. 
Age, presenting symptoms, and size of the
ovarian tumor are not predictive of malignan-
cy, but imaging features and tumor markers
are useful. US is the imaging modality of
choice in cases of ovarian masses in children,
particularly for the initial workup; the pres-
ence of more solid components in the tumor is
a definite feature that predicts malignancy. CT
scan and MRI are useful in cases of undefined
Case Report
Table 1. Hormonal data and serum tumor markers at diagnosis and during follow up.
At diagnosis of central At diagnosis of granulosa Post 
precocious puberty cell tumor surgery
Basal LH (mU/mL) 0.2 0.2 0.1
Peak LH (mU/mL) 6.4 n.e. n.e.
Basal FSH (mU/mL) 2.3 0.1 0.6
Peak FSH (mU/mL) 13.4 n.e. n.e.
18-β-estradiol (pg/mL) 10.1 65 4.7
CA125 (U/mL; n.v. 0-35) 9.1 74.3 8.9
Progesterone (ng/mL) 0.2 1.7 0.2
CEA (ng/mL; n.v. 0-5) <0.5 0.5 <0.5
AFP (U/mL; n.v. 0-12) 5.8 5.4 5.8
βhCG (mU/mL; n.v. 0-5) <2 <2 <2
LH, luteinizing hormone; FSH, follicle-stimulating hormone; CA125, Cancer Antigen-125; CEA, carcinoembryonic antigen; AFP, alpha-fetopro-
tein; hCG, beta human chorionic gonadotropin; n.v., normal values; n.e., not evaluated.
Table 2. Ovarian tumor markers.
Histology FP βhCG LDH CA-125 CEA CA 19.19 Inhibin
Germinal tumors
Endodermal sinus tumor + - + + - + -
Teratoma (immature) + - - + - + -
Dysgerminoma - + + + - + -
Embryonal CA + + - - - + -
Chorio CA - + - - - + -
Epithelial cell tumors + + + + + + -
Sex stromal cell tumors + - + + - - +
Figure 1. A) Ultrasound images of the ovaries at diagnosis of central precocious puberty.
Ultrasound images (B), magnetic resonance imaging (C) and gross examination (D) of
the ovarian mass.
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mass if malignancy is suspected and before
any surgery. They give additional information
about the nature of the tumor and the pres-
ence of pelvic and para-aortic lymph nodes
and, therefore, increases the accuracy of the
diagnosis of ovarian malignancy.8
The evaluation of serum tumor markers,
even if these are often non-specific, is very
important for the differential diagnosis in
pediatric ovarian masses. The surgical man-
agement and approach will be based on test
results and examination findings with the aim
of preserving the girl’s fertility.5,9,10 Tumor
markers such as AFP, β-hCG, CA 125, CEA, CA
19.9 and inhibin could indicate the presence of
ovarian malignancy (Table 2). 
Thus, associating the marker findings to
clinical symptoms together with imaging
reports, intraoperative aspect and an eventual
intraoperative histopathology are all recom-
mended to promote a confident differential
diagnosis. 
Ovarian malignancy at any age is treated by
oophorectomy or salpingo-oophorectomy of the
affected adnexa and surgical staging.11 The
prognosis of ovarian tumors in children is
excellent if they are detected in an early stage.4
The risk of re-occurrence of benign tumors in
the controlateral ovary is approximately 10%
thus requiring regular ultrasound monitoring.
Malignant tumors have a good prognosis for
survival if treated properly.2
Conclusions
In conclusion, in our patient, JGCT was
detected after the diagnosis of central preco-
cious puberty. The pathogenesis of ovarian
GCT is still unknown, but in this case the over-
stimulation of the FSH or aberrant activation
of FSH receptors may have contributed to the
development of the mass. The association
between central precocious puberty and granu-
losa cell tumors might not be coincidental.
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